Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
72 participants
OBSERVATIONAL
2019-10-31
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antidepressant Treatments and Cognitive Function of Bipolar Patients
NCT04564573
Investigation of Factors Associated With Preserved Cognitive Function in Bipolar Disorder
NCT04454073
Brain Voxel-based Morphometry in Bipolar Mania
NCT03181698
Study of Degenerescence CSF Hallmarks in Older Bipolar Patients
NCT02836054
Study Efficacy of Enhancing Cognitive Reserve in Patients With a First Bipolar Episode
NCT06081634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biplar patients
diagnosed by DSM-5 and divided to manic,depressed and mixed last episod
No interventions assigned to this group
controlled subject
not have any medical or psychatric problem affect cognition
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Of both sex
* Diagnosed as bipolar by DSM-5(patient)
Exclusion Criteria
* Substance abuse or dependence (except nicotine and caffeine)in last month.
* Somatic treatment with drugs known to affect cognitive status (cortisol, antihistamines, etc.)
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Salama Ahmed Omar
Assessment of cognitive function in bipolar patients
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cognition in bipolar patients
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.